MOTS-C is a small peptide encoded not within the nuclear genome, but within the mitochondrial genome — specifically from the 12S ribosomal RNA gene. First characterized in 2015, it belongs to a growing class of signaling molecules called mitochondrial-derived peptides (MDPs). Its mitochondrial origin makes it unusual among peptides studied in metabolic and cellular biology, and that distinction is a large part of what draws sustained research attention. As a 16-amino acid peptide, MOTS-C is compact enough to be synthesized at high purity yet biologically active enough to produce measurable effects in cellular and preclinical models, making it a practical and scientifically compelling research tool.
Molecular Structure and Key Properties
MOTS-C consists of 16 amino acids with the sequence MRWQEMGYIFYPRKLR. Its molecular weight is approximately 2,174 daltons, placing it firmly in the small peptide category. The sequence is notably conserved across species, which researchers interpret as a signal of functional significance — peptides that evolution has preserved tend to serve roles that matter to basic cellular processes. In solution, MOTS-C is water-soluble, which simplifies handling compared to hydrophobic peptides that require organic co-solvents for dissolution. Its relatively small size also means it can be synthesized using standard solid-phase peptide synthesis methods and characterized with confidence using common analytical techniques. These practical properties contribute to its accessibility as a laboratory reagent, and its defined, short sequence makes purity assessment straightforward.
Research Applications
Research involving MOTS-C centers primarily on mitochondrial signaling, cellular metabolism, and the mechanisms by which mitochondria communicate with other cellular compartments. In vitro studies have examined how MOTS-C interacts with pathways tied to glucose metabolism, including the AMPK pathway — a well-studied sensor of cellular energy status. Researchers have used cell culture models to measure changes in glucose uptake, fatty acid oxidation, and oxidative stress markers following treatment with synthetic MOTS-C.
Preclinical work in rodent models has expanded the scope of investigation. Studies have tracked MOTS-C levels across tissues and observed how those concentrations shift under conditions such as high-fat dietary challenge, aging, and exercise protocols. Researchers have also examined how exogenously administered MOTS-C affects gene expression profiles in skeletal muscle and liver tissue, with particular attention to pathways involved in mitochondrial biogenesis and insulin signaling. The peptide has drawn interest from aging biology researchers as well, given that endogenous MOTS-C levels appear to decline with age in animal models — a finding that positions it as a marker and potential mechanistic subject in longevity research.
Analytical Use and Sourcing Considerations
Researchers working with MOTS-C typically prepare stock solutions in sterile water or phosphate-buffered saline at concentrations in the micromolar range, then dilute for individual assays. Aliquoting immediately after reconstitution and storing at -80°C minimizes degradation from repeated freeze-thaw cycles. As with most peptides, exposure to repeated temperature fluctuation is the primary cause of sample degradation, so single-use aliquots are standard practice in most protocols.
Purity is a critical sourcing variable. For mechanistic cell-based assays, researchers typically require HPLC purity of 95% or greater to ensure that observed effects are attributable to MOTS-C rather than synthesis byproducts or truncated sequences. Certificate of Analysis documentation should include HPLC chromatograms and mass spectrometry confirmation of the correct molecular weight. Amino acid analysis or additional sequencing data adds further confidence for high-stakes applications. Sourcing from a supplier that performs in-house quality control — rather than relying solely on third-party certificates — reduces the risk of lot-to-lot variability affecting experimental reproducibility.
MOTS-C continues to attract research interest because it occupies a rare position: a mitochondrially encoded signaling peptide with measurable activity in cellular models and a well-defined structure that supports rigorous analytical characterization. As the broader field of mitochondrial-derived peptides matures, MOTS-C remains one of the most studied and best-characterized members of that class.
For Research Use Only. Not for human consumption. All compounds described in this article are supplied as analytical-grade reagents for institutional in vitro laboratory research only. Not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
